Anixa Biosciences Inc
ANIX—
Build a strategy around ANIX
Anixa Biosciences Inc AI Insights
Informational only. Not investment advice.Snapshot
- Zero revenue TTM with 12M operating loss - pure R&D stage biotech burning 6.8M cash annually[Free Cash Flow TTM]
- Cash runway critical: 1.5M cash vs 6.8M annual burn = ~3 months without new financing[Cash and Equivalents]
- P/B of 6.3x on 16.6M equity for pre-revenue company - pricing in significant pipeline success[P/B Ratio]
Watch Triggers
- Cash and Equivalents: Falls below 1M or new financing announced — Signals imminent dilution timing and terms - critical for entry/exit
- Research and Development TTM: Significant increase or decrease from 5.4M run rate — Indicates pipeline acceleration or cash preservation mode
- Total Revenue TTM: Any revenue recognition above zero — First revenue would signal commercial milestone or partnership deal
Bull Case
Clean balance sheet with 0.01 debt/equity and 15.4M working capital provides flexibility for strategic deals without debt overhang
Debt to EquityWorking Capital
R&D spend of 5.4M (45% of opex) focused on pipeline - any clinical milestone could re-rate stock materially
Research and Development TTMOperating Expense TTM
Bear Case
Sub-3-month cash runway with 6.8M annual burn makes near-term dilution virtually certain at current 104M market cap
Cash and EquivalentsFree Cash Flow TTM
ROE of -58% and ROA of -55% TTM with zero revenue - equity value destruction accelerating
ROE TTMROA TTM
Bull vs Bear Balance
AI-generated sentiment analysis based on fundamental metrics and market conditions.
25%
Leverage ANIX's top insights and create a custom strategy based on them in seconds. Our AI editor does it all — in one click.
Forward Thesis
Imminent dilution or strategic transaction required within 6 months to fund operations
3-12mhigh
- 1.5M cash vs 6.8M annual burn rate
- 1.9M equity issuance TTM shows financing pattern
- Zero revenue path to profitability
Cash 1.5M, FCF -6.8M TTMIssuance of Capital Stock 1.9M TTMTotal Revenue 0 TTM
Valuation Context
Caveats
Public Strategies Rankings
See how Anixa Biosciences Inc ranks across different investment strategies.
Leverage ANIX's top insights and create a custom strategy in seconds. Our AI editor does it all — in one click.
ANIX Fundamentals
Professional, Scientific, and Technical Services → Professional, Scientific, and Technical Services
| Metric | Value | YoY Growth | Industry Percentile |
|---|---|---|---|
$88.6M | — | ||
$87.56M | — | ||
0.00 | — | ||
$0 | — | ||
$-0.34 | — | ||
0% | 0.0% | — | |
0% | 0.0% | — | |
$-7.17M | — | ||
-62.2% | -5.5% | — | |
Beta 5Y (Monthly) | unknown | — |
ANIX Dividend History
No dividends
ANIX Stock Splits
1 stock split
06/26/1525:1 split
ANIX SEC Filings
| Filing Date | Report Date | Report Type | Filing Link |
|---|---|---|---|
01/12/26 | 10/31/25 | 10-K | |
09/10/25 | 07/31/25 | 10-Q | |
05/28/25 | 04/30/25 | 10-Q | |
03/11/25 | 01/31/25 | 10-Q | |
01/10/25 | 10/31/24 | Unknown | |
09/06/24 | 07/31/24 | 10-Q | |
06/04/24 | 04/30/24 | 10-Q | |
03/12/24 | 01/31/24 | 10-Q | |
01/16/24 | 10/31/23 | 10-K | |
09/06/23 | 07/31/23 | 10-Q | |
06/14/23 | 04/30/23 | 10-Q | |
03/17/23 | 01/31/23 | 10-Q | |
01/04/23 | 10/31/22 | 10-K | |
09/09/22 | 07/31/22 | 10-Q | |
06/10/22 | 04/30/22 | 10-Q | |
03/11/22 | 01/31/22 | 10-Q | |
01/04/22 | 10/31/21 | 10-K | |
09/01/21 | 07/31/21 | 10-Q | |
06/10/21 | 04/30/21 | 10-Q | |
03/11/21 | 01/31/21 | 10-Q | |
01/07/21 | 10/31/20 | 10-K | |
09/08/20 | 07/31/20 | 10-Q | |
06/09/20 | 04/30/20 | 10-Q | |
03/09/20 | 01/31/20 | 10-Q | |
01/09/20 | 10/31/19 | 10-K | |
09/06/19 | 07/31/19 | 10-Q | |
06/12/19 | 04/30/19 | 10-Q | |
03/13/19 | 01/31/19 | 10-Q | |
01/11/19 | 10/31/18 | 10-K | |
09/07/18 | 07/31/18 | 10-Q | |
06/11/18 | 04/30/18 | 10-Q | |
03/09/18 | 01/31/18 | 10-Q | |
01/09/18 | 10/31/17 | 10-K | |
09/08/17 | 07/31/17 | 10-Q | |
05/26/17 | 04/30/17 | 10-Q | |
03/16/17 | 01/31/17 | 10-Q | |
12/07/16 | 10/31/16 | 10-K | |
08/19/16 | 07/31/16 | 10-Q | |
05/20/16 | 04/30/16 | 10-Q | |
02/19/16 | 01/31/16 | 10-Q | |
12/23/15 | 10/31/15 | 10-K | |
08/18/15 | 07/31/15 | 10-Q | |
05/22/15 | 04/30/15 | 10-Q | |
03/09/15 | 01/31/15 | 10-Q | |
01/29/15 | 10/31/14 | 10-K | |
09/15/14 | 07/31/14 | 10-Q | |
06/16/14 | 04/30/14 | 10-Q | |
03/17/14 | 01/31/14 | 10-Q | |
01/16/14 | 10/31/13 | 10-K | |
09/16/13 | 07/31/13 | 10-Q | |
06/14/13 | 04/30/13 | 10-Q | |
03/18/13 | 01/31/13 | 10-Q | |
01/29/13 | 10/31/12 | 10-K | |
09/14/12 | 07/31/12 | 10-Q | |
06/14/12 | 04/30/12 | 10-Q | |
03/16/12 | 01/31/12 | 10-Q | |
01/30/12 | 10/31/11 | 10-K | |
09/14/11 | 07/31/11 | 10-Q | |
06/14/11 | 04/30/11 | 10-Q | |
03/17/11 | 01/31/11 | 10-Q | |
02/14/11 | 10/31/10 | 10-K | |
09/14/10 | 07/31/10 | 10-Q | |
06/14/10 | 04/30/10 | 10-Q | |
03/17/10 | 01/31/10 | 10-Q | |
01/29/10 | 10/31/09 | 10-K | |
09/09/09 | 07/31/09 | 10-Q | |
06/18/09 | 04/30/09 | 10-Q | |
03/12/09 | 01/31/09 | 10-Q | |
01/16/09 | 10/30/08 | Unknown | -- |
09/19/08 | 07/31/08 | NT 10-Q | |
06/09/08 | 04/30/08 | 10-Q | |
03/12/08 | 01/29/08 | Unknown | -- |
01/15/08 | 10/30/07 | Unknown | -- |
09/17/07 | 07/31/07 | NT 10-Q | |
06/11/07 | 04/30/07 | 10-Q | |
03/12/07 | 01/28/07 | Unknown | -- |
01/16/07 | 10/30/06 | Unknown | -- |
09/11/06 | 07/31/06 | 10-Q | |
06/09/06 | 04/30/06 | 10-Q | |
03/10/06 | 01/28/06 | Unknown | -- |
01/31/06 | 10/30/05 | Unknown | -- |
09/09/05 | 07/31/05 | 10-Q | |
06/09/05 | 04/30/05 | 10-Q | |
03/10/05 | 01/28/05 | Unknown | -- |
01/18/05 | 10/30/04 | Unknown | -- |
09/02/04 | 07/31/04 | 10-Q | |
06/01/04 | 04/30/04 | 10-Q | |
02/27/04 | 01/29/04 | Unknown | -- |
12/22/03 | 10/30/03 | Unknown | -- |
09/15/03 | 07/31/03 | 10-Q | |
06/16/03 | 04/30/03 | 10-Q | |
03/17/03 | 01/28/03 | Unknown | -- |
02/13/03 | 10/30/02 | Unknown | -- |
09/16/02 | 07/31/02 | 10-Q | |
06/14/02 | 04/30/02 | 10-Q | |
03/14/02 | 01/28/02 | Unknown | -- |
01/29/02 | 10/30/01 | Unknown | -- |
09/14/01 | 07/31/01 | 10-Q | |
06/14/01 | 04/30/01 | 10-Q | |
03/19/01 | 01/28/01 | Unknown | -- |
01/29/01 | 10/30/00 | Unknown | -- |
09/14/00 | 07/31/00 | 10-Q | |
06/13/00 | 04/30/00 | 10-Q | |
03/15/00 | 01/29/00 | Unknown | -- |